Search Results - Tianxin Lin
- Showing 1 - 4 results of 4
-
1
Intravesical Disitamab Vedotin (RC48) for HER2‐Expressing High‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Single‐Arm, Dose–Escalation Phase I Trial Study by Xu Chen, Ming Huang, Zehua Chen, Chengjunyu Zhang, Bolin Pan, Chu Liu, Wentong Xu, Jianmin Fang, Jian Huang, Tianxin Lin
Published 2025-07-01
Article -
2
-
3
-
4
Immune System Alterations in the Development of Three Urological Cancers: Insights from Large-Sample Mendelian Randomization by Zhijian Chen, Ye Xie, Xiong Chen, Guibin Hong, Runnan Shen, Haishan Lin, Fan Jiang, Yun Wang, Mengyi Zhu, Yixuan Liu, Haoxuan Wang, Hongkun Yang, Tianxin Lin, Shaoxu Wu
Published 2025-06-01
Article